article thumbnail

Microbiological Applications: Bacterial Metabolism | BMG LABTECH

BMG Labtech

1-3 In this blog we examine bacterial metabolism: its scope, its interest to researchers, and how diverse applications, including those linked to metabolic control, measurement of metabolites and bacterial growth, can be determined using microplate readers. 2 in this blog adapted from this reference under license CC-BY 4.0.

article thumbnail

Vamorolone

New Drug Approvals

LAKHS VIEWS ON BLOG WORLDREACH AVAILABLEFOR YOUR ADVERTISEMENT join me on Linkedin Anthony Melvin Crasto Ph.D – India | LinkedIn join me on Researchgate RESEARCHGATE join me on Facebook Anthony Melvin Crasto Dr. | Facebook Twitter FACEBOOK join me on twitter Anthony Melvin Crasto Dr. | twitter +919321316780 call whatsaapp EMAIL.

FDA 62
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Sebetralstat

New Drug Approvals

LAKHS VIEWS ON BLOG WORLDREACH AVAILABLEFOR YOUR ADVERTISEMENT join me on Linkedin Anthony Melvin Crasto Ph.D – India | LinkedIn join me on Researchgate RESEARCHGATE join me on Facebook Anthony Melvin Crasto Dr. | Facebook Twitter FACEBOOK join me on twitter Anthony Melvin Crasto Dr. | twitter +919321316780 call whatsaapp EMAIL.

FDA 62
article thumbnail

ChEBI 2.0 Data Products

The ChEMBL-og

Many things to cover in one single post, for that reason, this is one in a series of blog posts describing ChEBI 2.0. Today, we are going to take a look at the ChEBI data products enhancements. What is new? Old ChEBI ChEBI 2.0 We have fixed that in the redevelopment.

article thumbnail

PIMICOTINIB

New Drug Approvals

History In December 2023, Abbisko Therapeutics entered into a licensing agreement for pimicotinib in all indications for China rights with Merck KGaA. [2] 2023) [link] ^ “Abbisko Therapeutics Announced the Entry into a Licensing Agreement for Pimicotinib (ABSK021) with Merck” [link] (Press release). 6] The U.S. .

article thumbnail

Schedule III Marijuana Would Still Be Regulated Marijuana

FDA Law Blog: Biosimilars

Dispensing marijuana to patients, as required for other schedule III substances, would require a prescription issued for legitimate medical purpose by a DEA-registered and state licensed practitioner.

article thumbnail

What to Expect When you are Expecting…a Government Shutdown

FDA Law Blog: Biosimilars

For pre-license or pre-approval inspections, the outcome of a shutdown is less draconian as these are under the auspices of a user-fee program. If the shutdown were to occur on Monday March 3 rd , inspectors may be recalled from active or on-going inspections to be placed on furlough.